Purchase Order 36C25024P1600

Award Date 8/1/24
Potential Completion Date 7/31/25
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Cincinnati, OH 45220, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed

This is a sole source, firm-fixed price contract awarded by the Department of Veterans Affairs (VA), Veterans Health Administration, Network Contracting Office 10 in Cincinnati, Ohio to Diasorin Molecular, LLC. The $15,118 contract is for a Diasorin Liaison MDX service agreement to support the Cincinnati VA Medical Center. The contract has a performance period through July 31, 2025.

Diasorin Molecular is a foreign-owned, for-profit manufacturer of medical diagnostic products and testing equipment. The company has been a key supplier of COVID-19 tests, analyzers, and related equipment to the VA and Department of Health and Human Services during the pandemic. Diasorin Molecular also provides herpes and cytomegalovirus testing reagents to VA hospitals. This contract award is not set aside and is being made without competition, as Diasorin Molecular is the sole source provider of the required Diasorin Liaison MDX services.

Generated 9/26/24, 9:36 AM